"10.1371_journal.pone.0124158","plos one","2015-05-26T00:00:00Z","Alexander J Probst; Thomas Weinmaier; Todd Z DeSantis; Jorge W Santo Domingo; Nicholas Ashbolt","Department for Bioinformatics, Second Genome Inc., South San Francisco, California, United States of America; U.S. Environmental Protection Agency, Cincinnati, Ohio, United States of America","Conceived and designed the experiments: JSD NA TD. Performed the experiments: JSD AP TW TD. Analyzed the data: JSD AP TW TD NA. Contributed reagents/materials/analysis tools: JSD AP TW TD. Wrote the paper: JSD AP TW TD NA.","TD, TW and AP are paid employees of Second Genome, Inc. (www.secondgenome.com). Their association with Second Genome does not alter the authors adherence to all journal policies. Second Genome is a gastrointestinal therapeutics company with a pipeline of intestinal microbiome modulators that impact metabolic diseases and IBD. The publication of effects of WGA on different environmental microbial communities does not influence the value of any of Second Genomes therapeutic assets.","2015","05","Alexander J Probst","AJP",5,TRUE,3,4,5,5,TRUE,TRUE,FALSE,0,NA,FALSE
